# Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity

> **NCT05150080** · — · UNKNOWN · sponsor: **Kai Mu** · enrollment: 40 (estimated)

## Conditions studied

- Cardio-oncology
- Hematopoietic Stem Cell Transplantation
- Cardiotoxicity
- Cyclophosphamide
- Echocardiography

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05150080
- **Lead sponsor:** Kai Mu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-10
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05150080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05150080, "Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05150080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*